変異体 rs13045は,EIF2AK3の発現を低下させ,川崎病におけるMAPK-ERK1/2経路経由による炎症性サイトカイン分泌を抑制する
Wan Yang1, Wenli Guo2, Zhouping Wang3
1Department of Clinical Biological Resource Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China; Department of Cardiac Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China; Department of Pediatrics, the Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, 511518, China.
Biochimica et biophysica acta. Molecular basis of disease
|September 5, 2025
まとめ
この研究は,EIF2AK3を川崎病 (KD) の感受性における新たな遺伝因子として特定した. EIF2AK3をターゲットにすることで,炎症を軽減することで,KD血管炎の新たな治療戦略を提供することができる.
科学分野:
- 遺伝学
- 免疫学
- 分子生物学
背景:
- カワサキ病 (KD) は,子供における心疾患の主要な原因です.
- KDの遺伝的および分子的基盤を理解することは 効果的な治療法の開発に不可欠です
研究 の 目的:
- 川崎病の病原性におけるEIF2AK3の役割を調査する.
- EIF2AK3がKDに関連する血管炎に影響を与える分子メカニズムを解明する.
- KDの潜在的な治療目標としてEIF2AK3を調査する.
主な方法:
- 910人のKD患者と848人の対照群におけるrs13045ポリモルフィズムの遺伝子型決定.
- qRT-PCR,ウェスタンブラット,免疫光を用いてEIF2AK3発現を評価する.
- EIF2AK3調節後の炎症誘発性サイトカインレベルと下流経路 (MAPK-ERK1/2) の調査
- Lactobacillus casei細胞壁抽出物 (LCWE) 誘発されたKDマウスモデルを使用した.
主要な成果:
- EIF2AK3 / rs13045ポリモルフィズムはKD感受性に関連しています.
- EIF2AK3の発現はKDで上調され,MAPK- ERK1/ 2経路経由で炎症誘発性サイトカインの放出を促進する.
- EIF2AK3の抑制により,血管炎と内皮からメゼンキマへの移行が,in vitroとin vivoで減少した.
- EIF2AK3の過剰発現は炎症を悪化させた.
結論:
- EIF2AK3は,川崎病の新たな感受性場所である.
- EIF2AK3は,MAPK- ERK1/ 2経路を通じた炎症誘発性サイトカインを上調することによって,KD血管炎を促進する上で重要な役割を果たします.
- EIF2AK3は,川崎病の管理のための有望な治療目標です.
関連する概念動画
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K


